Infectious Pulmonary Diseases

Pneumonia and tuberculosis: causes, classifications, pathogenesis, signs and symptoms, diagnosis, treatment, and infection control concerns.

Listen: Infectious Pulmonary Diseases

0:00
--:--

Infectious Pulmonary Diseases

Objectives - Identify facts and principles about pneumonia and tuberculosis, including causes, classifications, pathogenesis, signs and symptoms, diagnostic testing, treatment, and infection control concerns.


Pneumonia

Pneumonia is a lower respiratory tract infection that inflames the alveoli in one or both lungs. The alveoli may fill with fluid or pus.

PatternDescription
Lobar pneumoniaAcute inflammation of an entire lobe or lung
BronchopneumoniaPatchy foci of consolidation scattered in one or more lobes of one or both lungs

High-yield burden and risk points from the source:

  • Pneumonia is listed as the 8th leading cause of death in the U.S.
  • About 5 million cases occur annually.
  • About 1 million hospitalizations occur annually.
  • The source lists 50,622 deaths.
  • Risk groups include infants and young children, adults over 65, smokers, immunocompromised patients, and patients with recurring respiratory infections.

Pneumonia Causes

CategoryExamples From Source
BacteriaStreptococcus pneumoniae (pneumococcus), Haemophilus influenzae, Legionella pneumonia, Staphylococcus aureus
VirusesInfluenza A and B, corona, respiratory syncytial virus (RSV), adenoviruses
FungiCoccidioides causing coccidioidomycosis or valley fever, Aspergillus causing aspergillosis

Pneumonia Classification

Classification is based on where pneumonia was acquired. This helps predict the likely cause and determine empiric antimicrobial therapy.

ClassificationSource DefinitionCommon Pathogens or Notes
Community-acquired pneumonia (CAP)Acquired outside the hospital or care facilityAcute typical CAP includes pneumococcus, H. influenzae, and S. aureus. Acute atypical CAP includes Legionella pneumophila, Chlamydia pneumoniae, and viruses. Chronic CAP develops over weeks to months and includes M. tuberculosis and Histoplasma capsulatum.
Health care-associated pneumonia (HCAP)Develops in patients hospitalized in acute care for 2 or more days within the last 90 days, or in a long-term care facility in the last 30 daysHistory of recent health care exposure matters.
Hospital-acquired pneumonia (HAP)Develops more than 48 hours after hospital admission after CAP is ruled outCommon pathogens include P. aeruginosa, S. aureus including MRSA/MSSA, Klebsiella pneumoniae, and E. coli.
Ventilator-associated pneumonia (VAP)Develops more than 48 to 72 hours after intubationThe endotracheal tube impairs cough, allows microaspiration around the cuff, may develop a bacterial biofilm, allows secretion pooling around the cuff, and impairs mucociliary clearance.

Pneumonia Pathogenesis

Pneumonia can develop through several routes:

  • Inhalation of aerosolized particles from infectious patients, including COVID and TB.
  • Aspiration from the oropharynx during sleep or with impaired gag reflex, narcotic use, alcohol intoxication, or stroke.
  • Direct introduction into the lower airway, including frequent suctioning.
  • Spread from adjacent organs, such as sub-diaphragmatic or liver abscesses.
  • Spread through the blood, which is not common, such as right heart bacterial endocarditis or parasitic pneumonias.
  • Reactivation of latent infection in immunosuppressed patients, including Pneumocystis jiroveci, M. tuberculosis, and cytomegalovirus.

Pneumonia Clinical Signs

Common clinical signs include:

  • Pleuritic chest pain: sudden, intense, sharp, stabbing, or burning pain with inhaling and exhaling
  • Dyspnea
  • Expectoration and sputum production
  • Fever and chills
  • Muscle aches and stiffness
  • Cough
  • GI symptoms: nausea, vomiting, or diarrhea

Pneumonia Diagnosis

Diagnosis can include imaging, lab testing, and lower respiratory tract sampling.

CategoryExamples
Imaging studiesChest x-ray and computerized tomography (CT)
CulturesSputum, blood, pleural fluid, bronchoscopy, and mini BAL
Lab testsCBC with elevated or low white blood cell counts, Chem 7 for severity, ABG with low oxygenation values, HIV testing if specific infectious agents are suspected, AFB if TB is suspected, blood culture if bacteremia or septicemia is suspected, influenza testing, and RSV testing

Sputum Testing

Gram stain and culture place the sputum sample in growing media and analyze for growth. This helps determine the type of bacteria causing pneumonia.

Sensitivity testing determines whether a particular antibiotic or antifungal drug is likely to stop growth of the bacteria or fungi causing the infection.

Bronchoscopy and Mini BAL

Bronchoscopy can acquire lower respiratory tract samples when expectorated samples cannot be obtained or are nondiagnostic.

Bronchoscopy sampling methods include:

  • Bronchoalveolar lavage (BAL)
  • Routine brushing
  • Protected specimen brushing

Mini BAL uses a telescoping catheter to sample lower respiratory tract secretions and improve accurate diagnosis of lung infection.

Pneumonia Treatment

Treatment options listed in the source include:

  • Antibiotics
  • Antivirals
  • Antifungals
  • Oxygen
  • Fluids
  • Airway clearance therapy

Tuberculosis

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. It may affect almost any tissue of the body, especially the lungs, and is characterized by tubercles.

Tuberculosis Classification

TypeKey Point
Primary tuberculosis (active)Symptomatic shortly after exposure
Reactivation tuberculosis (latent)Symptomatic months to years after exposure
Endobronchial tuberculosisInvolves the airways and can result from primary or reactivation TB
Extrapulmonary tuberculosisSpread of M. tuberculosis beyond the lung; may spread to any organ through the lymphatic system

Active vs Latent TB

FindingActive TBLatent TB
SymptomsSymptomaticNo symptoms
InfectiousInfectiousNot infectious
PPDPositivePositive
IGRAPositivePositive
AFBNegative or positiveNegative
ImagingAbnormal imagingNormal imaging or granulomas

Tuberculosis Pathophysiology

TB is acquired by inhalation of airborne droplets containing M. tuberculosis.

Most individuals, 85-95% in the source, contain the infection and remain asymptomatic, but remain susceptible to reactivation later in life or if immunosuppressed.

The immune response produces a tubercle or caseous granuloma made of mononuclear cells and living TB, surrounded by white blood cells and fibroblasts that wall off the organism.

If the immune system cannot stop the infection:

  • The organism continues to multiply.
  • The center of the granuloma undergoes liquefaction called caseation.
  • M. tuberculosis can escape the granuloma and infect other portions of the lungs.

Caseous necrosis is cellular death that usually occurs in the lungs. The dead lung cells develop a crumbly, dull white appearance that resembles cheese.

Tuberculosis Symptoms

Symptoms listed in the source include:

  • Cough for at least 3 weeks
  • Barking cough
  • Hemoptysis
  • Fever
  • Weight loss
  • Night sweats
  • Fatigue
  • Chest pain

Tuberculosis Diagnosis

Diagnosis can include:

  • Patient clinical history and assessment
  • Chest x-ray
  • TB skin test using tuberculin purified protein derivative (PPD)
  • Acid-fast bacilli smear or sputum cultures (AFB)
  • Nucleic acid amplification test (NAAT), which detects genetic components of M. tuberculosis and is faster than AFB, less than 24 hours
  • Blood tests using interferon gamma release assay (IGRA)

Sputum samples are collected in the morning on 3 consecutive days. If the patient cannot produce sputum, induced sputum or bronchoscopy may be performed.

Tuberculosis Treatment

Treatment lasts 6 to 12 months in the source.

MedicationSource Note
PyrazinamideBactericide
EthambutolBacteriostatic; stops reproduction
RifampinBactericide
IsoniazideBactericide and bacteriostatic
StreptomycinAntibiotic

The Bacille Calmette-Guerin (BCG) vaccination is not used in the U.S. and causes a false positive PPD.

Tuberculosis Infection Control

Hospitalized patients with suspected or confirmed TB must be placed in respiratory isolation and follow airborne precautions.

Required precautions include:

  • Private room
  • Negative pressure
  • N95 masks for room entry
  • Proper N95 fit
  • Surgical mask for infected patients transported through the hospital

N95 designation means the respirator blocks at least 95% of 0.3 micron test particles if properly fitted.


High-Yield Review

TopicHigh-yield point
Pneumonia definitionLower respiratory tract infection that inflames alveoli, which may fill with fluid or pus
CAP vs HAPCAP is community acquired; HAP develops more than 48 hours after hospital admission after CAP is ruled out
VAPMore than 48-72 hours after intubation; ETT impairs cough and permits microaspiration and biofilm formation
Pneumonia diagnosisImaging, cultures, labs, bronchoscopy, and mini BAL may be used
TB spreadInhalation of airborne droplets containing M. tuberculosis
Active TBSymptomatic, infectious, positive PPD and IGRA, abnormal imaging
Latent TBNo symptoms, not infectious, positive PPD and IGRA, AFB negative
TB precautionsPrivate negative-pressure room and N95 mask for room entry